Israel's Wize Pharma Inc. said its shareholders approved a reverse stock split at a Feb. 19 special meeting.
Under the company's amended certificate of incorporation, the board can effect a reverse stock split by a ratio between 1-for-10 and 1-for-200 at any time before Feb. 19, 2019.